1261O Neoadjuvant nivolumab (N) + ipilimumab (I) vs chemotherapy (C) in the phase III CheckMate 816 trial

Mark M. Awad, Patrick M. Forde, Nicolas Girard, J.D. Spicer, C. Wang, Shun Lü, T. Mitsudomi, Enriqueta Felip, Stephen Broderick, Scott J. Swanson, J.R. Brahmer, Keith M. Kerr, G. Saylors, K-N. Chen, J.L. Cai, Javed Mahmood, J. Neely, David Balli, Nan Hu, M. Provencio Pulla